Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow-to-Debt Ratio
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2023, meaning its operating cash flow of Rs362.80 Million could theoretically repay 0% of its total liabilities (Rs6.56 Billion) in one year. See Aarti Pharmalabs Limited (AARTIPHARM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aarti Pharmalabs Limited Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Aarti Pharmalabs Limited across 6 annual periods. Also explore AARTIPHARM net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aarti Pharmalabs Limited (2020–2025)
Year-by-year debt coverage analysis for Aarti Pharmalabs Limited. For market capitalisation and broader financial context, see Aarti Pharmalabs Limited (AARTIPHARM) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | Rs3.32 Billion | Rs9.16 Billion | ▲ +38.0% |
| 2024 | 0.26x | Rs2.16 Billion | Rs8.25 Billion | ▼ -31.6% |
| 2023 | 0.38x | Rs2.63 Billion | Rs6.86 Billion | ▲ +673.6% |
| 2022 | -0.07x | Rs-437.04 Million | Rs6.53 Billion | — |
| 2021 | 0.00x | Rs0.00 | Rs232.71K | ▲ +100.0% |
| 2020 | -1.00x | Rs-186.75K | Rs186.75K | — |